Puzzle Medical Devices
Montréal
About Puzzle Medical Devices
Puzzle Medical is developing the ModulHeart, a modular percutaneous heart pump designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure who are not candidates for heart transplant or surgical mechanical circulatory support. The device’s modular design allows for hemodynamic support through multiple pumps anchored in parallel in the descending aorta. The design is expected to increase accessibility by enabling safe percutaneous implantation to support both renal and cardiac function, with low risk of bleeding, stroke, and pump thrombosis, while providing sustained symptom relief, reduced re-hospitalizations and improved overall quality of life. To date, Puzzle Medical has successfully: Γùï completed its first-in-human study with all patients experiencing improvements in cardiac and kidney function (2022); Γùï completed a Seed financing round (2021); Γùï built a strong Key Opinion Leaders committee (2021); Γùï received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation (2021).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $65.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2025)
- Website: puzzlemed.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/puzzle-medical-devices-117025 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.